Insider Transactions in Q3 2022 at Cytokinetics Inc (CYTK)
Insider Transaction List (Q3 2022)
| Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
|---|---|---|---|---|---|
|
Sep 19
2022
|
Robert I Blum President & CEO |
SELL
Open market or private sale
|
Direct |
10,000
-2.4%
|
$510,000
$51.42 P/Share
|
|
Sep 19
2022
|
Robert I Blum President & CEO |
BUY
Exercise of conversion of derivative security
|
Direct |
10,000
+2.35%
|
$70,000
$7.96 P/Share
|
|
Sep 12
2022
|
John T Henderson Director |
SELL
Open market or private sale
|
Direct |
21,759
-23.17%
|
$1,174,986
$54.94 P/Share
|
|
Sep 12
2022
|
John T Henderson Director |
BUY
Exercise of conversion of derivative security
|
Direct |
21,759
+18.81%
|
$87,036
$4.02 P/Share
|
|
Sep 08
2022
|
Fady Ibraham Malik EVP Research & Development |
SELL
Open market or private sale
|
Direct |
21,500
-11.33%
|
$1,096,500
$51.88 P/Share
|
|
Sep 08
2022
|
Fady Ibraham Malik EVP Research & Development |
BUY
Exercise of conversion of derivative security
|
Direct |
21,500
+10.17%
|
$193,500
$9.65 P/Share
|
|
Sep 07
2022
|
Robert I Blum President & CEO |
SELL
Open market or private sale
|
Direct |
10,000
-2.4%
|
$490,000
$49.11 P/Share
|
|
Sep 07
2022
|
Robert I Blum President & CEO |
BUY
Exercise of conversion of derivative security
|
Direct |
10,000
+2.35%
|
$70,000
$7.96 P/Share
|
|
Sep 02
2022
|
Sandford D Smith Director |
SELL
Open market or private sale
|
Direct |
11,369
-48.3%
|
$602,557
$53.97 P/Share
|
|
Sep 02
2022
|
Sandford D Smith Director |
BUY
Exercise of conversion of derivative security
|
Direct |
11,369
+15.98%
|
$272,856
$24.3 P/Share
|
|
Sep 01
2022
|
B Lynne Parshall Director |
SELL
Open market or private sale
|
Direct |
30,296
-75.18%
|
$1,575,392
$52.79 P/Share
|
|
Sep 01
2022
|
B Lynne Parshall Director |
BUY
Exercise of conversion of derivative security
|
Direct |
30,296
+24.26%
|
$242,368
$8.34 P/Share
|
|
Sep 01
2022
|
Wendall Wierenga Director |
SELL
Open market or private sale
|
Direct |
4,166
-25.5%
|
$216,632
$52.79 P/Share
|
|
Sep 01
2022
|
Wendall Wierenga Director |
BUY
Exercise of conversion of derivative security
|
Direct |
4,166
+20.32%
|
$24,996
$6.78 P/Share
|
|
Sep 01
2022
|
Santo J Costa Director |
SELL
Open market or private sale
|
Direct |
15,000
-60.0%
|
$780,000
$52.79 P/Share
|
|
Sep 01
2022
|
Santo J Costa Director |
BUY
Exercise of conversion of derivative security
|
Direct |
15,000
+26.79%
|
$150,000
$10.07 P/Share
|
|
Aug 17
2022
|
Robert I Blum President & CEO |
SELL
Open market or private sale
|
Direct |
10,000
-2.39%
|
$500,000
$50.11 P/Share
|
|
Aug 17
2022
|
Robert I Blum President & CEO |
BUY
Exercise of conversion of derivative security
|
Direct |
10,000
+2.33%
|
$70,000
$7.96 P/Share
|
|
Aug 05
2022
|
Edward M. Md Kaye Director |
SELL
Open market or private sale
|
Direct |
11,428
-47.61%
|
$571,400
$50.0 P/Share
|
|
Aug 05
2022
|
Edward M. Md Kaye Director |
BUY
Exercise of conversion of derivative security
|
Direct |
11,428
+32.25%
|
$91,424
$8.75 P/Share
|
|
Aug 01
2022
|
Robert I Blum President & CEO |
SELL
Open market or private sale
|
Direct |
10,000
-2.39%
|
$410,000
$41.26 P/Share
|
|
Aug 01
2022
|
Robert I Blum President & CEO |
BUY
Exercise of conversion of derivative security
|
Direct |
10,000
+2.33%
|
$70,000
$7.96 P/Share
|
|
Jul 18
2022
|
Robert I Blum President & CEO |
SELL
Open market or private sale
|
Direct |
10,000
-2.38%
|
$400,000
$40.49 P/Share
|
|
Jul 18
2022
|
Robert I Blum President & CEO |
BUY
Exercise of conversion of derivative security
|
Direct |
10,000
+2.33%
|
$70,000
$7.96 P/Share
|
|
Jul 14
2022
|
Fady Ibraham Malik EVP Research & Development |
SELL
Open market or private sale
|
Direct |
21,500
-11.33%
|
$924,500
$43.43 P/Share
|
|
Jul 14
2022
|
Fady Ibraham Malik EVP Research & Development |
BUY
Exercise of conversion of derivative security
|
Direct |
21,500
+10.17%
|
$193,500
$9.65 P/Share
|
|
Jul 06
2022
|
Robert I Blum President & CEO |
SELL
Open market or private sale
|
Direct |
10,000
-2.38%
|
$440,000
$44.38 P/Share
|
|
Jul 06
2022
|
Robert I Blum President & CEO |
BUY
Exercise of conversion of derivative security
|
Direct |
10,000
+2.33%
|
$70,000
$7.96 P/Share
|
|
Jul 01
2022
|
Nancy Wysenski Director |
BUY
Grant, award, or other acquisition
|
Direct |
137
+1.2%
|
$5,617
$41.0 P/Share
|
|
Jul 01
2022
|
Sandford D Smith Director |
BUY
Grant, award, or other acquisition
|
Direct |
137
+1.11%
|
$5,617
$41.0 P/Share
|
|
Jul 01
2022
|
Edward M. Md Kaye Director |
BUY
Grant, award, or other acquisition
|
Direct |
274
+2.13%
|
$11,234
$41.0 P/Share
|
|
Jul 01
2022
|
John T Henderson Director |
BUY
Grant, award, or other acquisition
|
Direct |
487
+1.98%
|
$19,967
$41.0 P/Share
|
|
Jul 01
2022
|
Muna Bhanji Director |
BUY
Grant, award, or other acquisition
|
Direct |
274
+2.47%
|
$11,234
$41.0 P/Share
|
|
Jul 01
2022
|
Wendall Wierenga Director |
BUY
Grant, award, or other acquisition
|
Direct |
137
+1.11%
|
$5,617
$41.0 P/Share
|